A detailed history of Apexium Financial, LP transactions in Iridex Corp stock. As of the latest transaction made, Apexium Financial, LP holds 100,529 shares of IRIX stock, worth $98,518. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100,529
Previous 65,695 53.02%
Holding current value
$98,518
Previous $57,000 101.75%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 17, 2025

BUY
$0.89 - $1.53 $31,002 - $53,296
34,834 Added 53.02%
100,529 $115,000
Q3 2022

Nov 14, 2022

BUY
$2.41 - $3.41 $158,324 - $224,019
65,695 New
65,695 $158,000

Others Institutions Holding IRIX

About IRIDEX CORP


  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $15.7M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track This Portfolio

Track Apexium Financial, LP Portfolio

Follow Apexium Financial, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apexium Financial, LP, based on Form 13F filings with the SEC.

News

Stay updated on Apexium Financial, LP with notifications on news.